On July 31, the New Brunswick, N.J.-based company announced plans to cut its work force by up to 4 percent, or 4,820 jobs, because of the stent decline, as well as slumping sales of a key drug and looming patent expirations.
英
美
- 7月31日，這個(gè)位于新澤西州新不倫瑞克的公司宣布，因為支架銷(xiāo)售的減少、一個(gè)關(guān)鍵藥物的銷(xiāo)售量降低和即將到來(lái)的藥物過(guò)期，公司計劃裁員4%25，也就是4820個(gè)職位。
